Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement-Reference-Cited by-同舟云学术

Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement

Published:2015-01-14 Issue:10 Volume:22 Page:792-799
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Artenie A. A.¹²,Jutras-Aswad D.¹³,Roy É.⁴⁵,Zang G.¹,Bamvita J.-M.¹,Lévesque A.¹²,Bruneau J.¹²⁶

Affiliation:

1. Research Center; Centre Hospitalier de l'Université de Montréal (CRCHUM); Montréal QC Canada

2. Department of Family Medicine; Faculty of Medicine; McGill University; Montréal QC Canada

3. Department of Psychiatry; Faculty of Medicine; Université de Montréal; Montréal QC Canada

4. Addiction Research and Study Program; Faculty of Medicine and Health Sciences; Université de Sherbrooke; Longueuil QC Canada

5. Montréal Public Health Department; Agence de la santé et des services sociaux de Montréal; Montréal QC Canada

6. Department of Family and Emergency Medicine; Faculty of Medicine; Université de Montréal; Montréal QC Canada

Funder

Canadian Institutes of Health Research

Réseau SIDA et Maladies Infectieuses du Fonds de la Recherche en Santé du Québec

National CIHR Research Training Program in Hepatitis C

University of Sherbrooke

Charles Lemoyne Hospital Foundation

University of Sherbrooke Foundation in Québec, Canada

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12393/fullpdf

Reference50 articles.

1. Epidemiology and natural history of HCV infection;Hajarizadeh;Nat Rev Gastroenterol Hepatol,2013

2. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

3. HCV reinfection studies and the door to vaccine development;Grebely;J Hepatol,2009

4. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services;Centers for Disease Control and Prevention;MMWR Recomm Rep,2012

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugs;Drug and Alcohol Dependence Reports;2024-03

2. Barriers to and facilitators of screening for cervical and breast cancer: Experiences of non-adherent women with current or previous drug use;Preventive Medicine Reports;2024-02

3. How an emergency department is organized to provide opioid-specific harm reduction and facilitators and barriers to harm reduction implementation: a systems perspective;Harm Reduction Journal;2023-09-21

4. HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers;International Journal of Drug Policy;2023-03

5. Service Utilization among Persons Who Inject Drugs Attending a Syringe Exchange Program in New York State;Substance Use & Misuse;2023-02-22